Reaction equation
[N:1]1[C:10]2[C:5](=[CH:6][C:7]([CH2:11][N:12]3[C:16]4=[N:17][C:18]([C:21](=O)[CH3:22])=[CH:19][N:20]=[C:15]4[N:14]=[N:13]3)=[CH:8][CH:9]=2)[CH:4]=[CH:3][CH:2]=1.[CH3:24][NH:25][C:26]([N:28]([CH3:30])[NH2:29])=[O:27]>>[CH3:24][NH:25][C:26]([N:28]([CH3:30])/[N:29]=[C:21](/[C:18]1[N:17]=[C:16]2[N:12]([CH2:11][C:7]3[CH:6]=[C:5]4[C:10](=[CH:9][CH:8]=3)[N:1]=[CH:2][CH:3]=[CH:4]4)[N:13]=[N:14][C:15]2=[N:20][CH:19]=1)\[CH3:22])=[O:27]Participants
3
Procedure
The title compound was prepared in analogy to the synthesis of example 52 from 1-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)ethanone and N,1-dimethyl-hydrazinecarboxamide. 1H-NMR (400 MHz, DMSO-d6) δ ppm 9.73 (s, 1H), 8.89 (m, 1H), 8.36 (dd, 1H), 8.03 (s, 1H), 8.00 (d, 1H), 7.53 (dd, 1H), 7.19 (m, 1H), 6.21 (s, 2H), 3.31 (s, 3H), 2.72 (d, 3H), 2.49 (d, 3H). LCMS (method B): [MH]+=390, tR=1.99 min.
Sources & evidence
- ORD record
- ord-2a9ea274b39a4522b50d812b5d0d152d
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08497368B2
Linked notes
Loading…